Malawi Liverpool Wellcome Programme

Search
Close this search box.

Publications

Intestinal Perforations Associated With a High Mortality and Frequent Complications During an Epidemic of Multidrug-resistant Typhoid Fever in Blantyre, Malawi.

Olgemoeller F, Waluza JJ, Zeka D, Gauld JS, Diggle PJ, Read JM, Edwards T, Msefula CL, Chirambo A, Gordon MA, Thomson E, Heyderman RS, Borgstein E, Feasey NA,

Implementation of Antibody Rapid Diagnostic Testing versus Real-Time Reverse Transcription-PCR Sample Pooling in the Screening of COVID-19: a Case of Different Testing Strategies in Africa.

Nyazika TK, Kaela R, Mugoni M, Musomekwa K, Kyei-Baafour E, Chiwanda S, Mapondera PT, Makawa TS, Sithole EM, Mavunganidze G, Manasa J, Jambo KC, Musarurwa C,

Conducting clinical trials in sub-Saharan Africa: challenges and lessons learned from the Malawi Cryptosporidium study.

Toto N, Douglas E, Gmeiner M, Barrett LK, Lindblad R, Makhaza L, Nedi W, Phulusa J, Quinnan GV, Sawyer LA, Thole H, Van Voorhis WC, Iroh Tam PY,

Report of the 1st African Enteric Viruses Genome Initiative (AEVGI) Data and Bioinformatics Workshop on whole-genome analysis of some African rotavirus strains held in Bloemfontein, South Africa.

Nyaga MM, Sabiu S, Ndze VN, Dennis FE, Jere KC,

Febrile Illness Evaluation in a Broad Range of Endemicities (FIEBRE): protocol for a multisite prospective observational study of the causes of fever in Africa and Asia.

Hopkins H, Bassat Q, Chandler CI, Crump JA, Feasey NA, Ferrand RA, Kranzer K, Lalloo DG, Mayxay M, Newton PN, Mabey D, FIEBRE Consortium,

A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.

Alufandika M, Lawrence DS, Boyer-Chammard T, Kanyama C, Ndhlovu CE, Mosepele M, Tugume L, Meya D, Boulware DR, Rhein J, Muzoora C, Youssouf N, Molloy SF, Schutz C, Lortholary O, Meintjes G, Mwandumba HC, Harrison TS, Jarvis JN, and the AMBITION-cm Study Group,

Parasite histones are toxic to brain endothelium and link blood barrier breakdown and thrombosis in cerebral malaria.

Moxon CA, Alhamdi Y, Storm J, Toh JMH, McGuinness D, Ko JY, Murphy G, Lane S, Taylor TE, Seydel KB, Kampondeni S, Potchen M, O’Donnell JS, O’Regan N, Wang G, García-Cardeña G, Molyneux M, Craig AG, Abrams ST, Toh CH,

Evaluation of a standardised Vi poly-l-lysine ELISA for serology of Vi capsular polysaccharide antibodies.

Rigsby P, Beamish E, Hockley J, Atkinson E, Hitri K, Jones E, Yang JS, Qadri F, Bachtiar NS, Elias SC, Goel A, Mishra R, Dugyala R, Pasetti MF, Meiring JE, Mbewe M, Gordon MA, Pollard AJ, Logan A, Rijpkema S, anti-Vi IgG working group,

Future schistosome hybridizations: Will all Schistosoma haematobium hybrids please stand-up!

Stothard JR, Kayuni SA, Al-Harbi MH, Musaya J, Webster BL,

COVID-19 in Africa: preparing for the storm.

Chakaya J, Binegdie A, Irungu A, Pearson B, Gray D, Zar HJ, Schewitz I, Kagima J, Mortimer K, Ozoh OB, Masekela R, Gordon SB, Worodria W, Aluoch J,